SOX4 and neoplasm: In vivo validation using a xenograft tumor formation assay (Fig. 2I) showed that SOX4 knockdown in the HepG2 cell line significantly reduced tumor growth rate and final tumor volume Conversely, SOX4 overexpression in Huh7 cells accelerated tumor growth and increased final tumor volume (Fig. 2J).